EP1904076A4 - Compositions penetrant dans le noyau de la cellule - Google Patents

Compositions penetrant dans le noyau de la cellule

Info

Publication number
EP1904076A4
EP1904076A4 EP05802798A EP05802798A EP1904076A4 EP 1904076 A4 EP1904076 A4 EP 1904076A4 EP 05802798 A EP05802798 A EP 05802798A EP 05802798 A EP05802798 A EP 05802798A EP 1904076 A4 EP1904076 A4 EP 1904076A4
Authority
EP
European Patent Office
Prior art keywords
penetrating
compositions
core
cell
compositions penetrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05802798A
Other languages
German (de)
English (en)
Other versions
EP1904076A1 (fr
Inventor
Ewald Hannappel
Thomas Huff
Allan L Goldstein
David Crockford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich Alexander Universitaet Erlangen Nuernberg
RegeneRx Biopharmaceuticals Inc
Original Assignee
Friedrich Alexander Universitaet Erlangen Nuernberg
RegeneRx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Alexander Universitaet Erlangen Nuernberg, RegeneRx Biopharmaceuticals Inc filed Critical Friedrich Alexander Universitaet Erlangen Nuernberg
Publication of EP1904076A1 publication Critical patent/EP1904076A1/fr
Publication of EP1904076A4 publication Critical patent/EP1904076A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
EP05802798A 2005-05-27 2005-10-03 Compositions penetrant dans le noyau de la cellule Withdrawn EP1904076A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68499305P 2005-05-27 2005-05-27
PCT/US2005/035716 WO2006130171A1 (fr) 2005-05-27 2005-10-03 Compositions penetrant dans le noyau de la cellule

Publications (2)

Publication Number Publication Date
EP1904076A1 EP1904076A1 (fr) 2008-04-02
EP1904076A4 true EP1904076A4 (fr) 2009-12-09

Family

ID=37481967

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05802798A Withdrawn EP1904076A4 (fr) 2005-05-27 2005-10-03 Compositions penetrant dans le noyau de la cellule

Country Status (9)

Country Link
EP (1) EP1904076A4 (fr)
JP (1) JP2008542265A (fr)
KR (1) KR20080016675A (fr)
CN (1) CN101184498A (fr)
AU (1) AU2005332297A1 (fr)
CA (1) CA2607701A1 (fr)
IL (1) IL187217A0 (fr)
MX (1) MX2007014803A (fr)
WO (1) WO2006130171A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2718774A1 (fr) * 2008-03-17 2009-12-17 Regenerx Biopharmaceuticals, Inc. Fragments ameliores de beta thymosine
CN110790821B (zh) * 2019-11-19 2022-09-02 南阳师范学院 一种细胞核穿透肽及其用途
CN115266995B (zh) * 2022-08-02 2023-10-13 兆科(广州)眼科药物有限公司 一种生发肽制剂中有关物质的分析方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090345A2 (fr) * 2000-05-22 2001-11-29 Children's Hospital Of Philadelphia Procedes et compositions pour augmenter la liberation d'un acide nucleique dans une cellule
WO2005007118A2 (fr) * 2003-07-18 2005-01-27 Regenerx Biopharmaceuticals, Inc. Traitement de prevention des dommages causes par la radioexposition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613369A4 (fr) * 2003-03-31 2008-10-01 Regenerx Biopharmaceuticals Compositions et procedes d'administration de thymosine beta 4, d'analogues, d'isoformes et autres derives
WO2004099768A1 (fr) * 2003-05-05 2004-11-18 Regenerx Biopharmaceuticals, Inc. Procede de detection d'apparition de trouble physiologique chez un sujet

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090345A2 (fr) * 2000-05-22 2001-11-29 Children's Hospital Of Philadelphia Procedes et compositions pour augmenter la liberation d'un acide nucleique dans une cellule
WO2005007118A2 (fr) * 2003-07-18 2005-01-27 Regenerx Biopharmaceuticals, Inc. Traitement de prevention des dommages causes par la radioexposition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUFF THOMAS ET AL: "Nuclear localisation of the G-actin sequestering peptide thymosin beta4.", JOURNAL OF CELL SCIENCE 15 OCT 2004, vol. 117, no. Pt 22, 15 October 2004 (2004-10-15), pages 5333 - 5341, XP002551253, ISSN: 0021-9533 *
See also references of WO2006130171A1 *

Also Published As

Publication number Publication date
KR20080016675A (ko) 2008-02-21
EP1904076A1 (fr) 2008-04-02
CN101184498A (zh) 2008-05-21
IL187217A0 (en) 2008-02-09
JP2008542265A (ja) 2008-11-27
AU2005332297A1 (en) 2006-12-07
MX2007014803A (es) 2008-04-21
CA2607701A1 (fr) 2006-12-07
WO2006130171A1 (fr) 2006-12-07

Similar Documents

Publication Publication Date Title
BRPI0810472A2 (pt) Métodos relacionados à glicosilação da superfície celular
NO2018027I2 (no) [18F]FACBC eller fluciklovin
PT1943264E (pt) Análogos de oligonucleosídeos incorporando neles 5-azacitosina
BRPI0810813A2 (pt) Agentes anti-hipertensivos de ação dupla
EP1838220A4 (fr) Bioptome
DK1951885T3 (da) Fructooligosaccharidfremstilling in situ og saccharosereduktion
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
EP1788047A4 (fr) Composition hydrofuge/oleofuge
EP2030606A4 (fr) Composition de colorant capillaire en étui monopièce
NO20055686D0 (no) Sammensetning
EP1909097A4 (fr) Biocapteur et cellule à biocapteur
EP1897558A4 (fr) Preparation solide
EP1891264A4 (fr) Cellule de flottation
EP1942232A4 (fr) Structure de construction
EP1865042A4 (fr) Composition anti-gel
EP1884275A4 (fr) Corps de structure alvéolaire
EP1849798A4 (fr) Peptide capable de penetrer dans les cellules
EP1870942A4 (fr) Cellule solaire
EP2155914A4 (fr) Améliorations dans la production de ferroalliages
DK1967534T3 (da) Klæbende sammensætning
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
DE602006016400D1 (de) Damit
EP1920026A4 (fr) Solution de microgravure amelioree
DE602005007582D1 (de) In biologischen proben
DE602006011271D1 (de) Anthelminthische zusammensetzung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1114564

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20091106

17Q First examination report despatched

Effective date: 20100212

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1114564

Country of ref document: HK